Sincalide for Injection 5 mcg (Sincalide POWDER FOR SOLUTION) 5 MCG

Sincalide for Injection 5 mcg is a powder for solution used for diagnostic purposes. This intravenous medication is manufactured by Avir Pharma Inc. in Canada.

Strength

5 MCG

Manufacturer / TM Owner

AVIR PHARMA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sincalide for Injection 5 mcg is primarily used in diagnostic procedures to stimulate gallbladder contraction and bile flow. It is often employed in imaging studies to assess gallbladder function and bile duct patency. This medication helps in identifying potential issues related to bile flow and gallbladder health.

Side Effects

When administered intravenously, Sincalide for Injection 5 mcg typically induces gallbladder contraction, which can aid in diagnostic imaging. Common effects may include temporary discomfort or mild pain in the abdomen as the gallbladder contracts. These effects are generally short-lived and part of the diagnostic process.

Precautions & Warnings

Sincalide for Injection 5 mcg should be handled with care, ensuring proper reconstitution and administration by healthcare professionals. It is important to follow the prescribed guidelines for use and to monitor the patient during the procedure. Always check for any signs of allergic reactions or adverse effects.

Avoid Interactions

Sincalide for Injection 5 mcg may interact with other medications, particularly those affecting bile flow or gallbladder function. It is advisable to inform healthcare providers about all current medications before undergoing diagnostic procedures involving Sincalide. Alcohol and certain substances may also influence the effectiveness or safety of this medication.

Frequently Asked Questions

Sincalide for Injection 5 mcg is used in diagnostic procedures to stimulate gallbladder contraction and bile flow, aiding in imaging studies.

Sincalide for Injection 5 mcg is administered intravenously after reconstituting the powder for solution.

Common effects include temporary abdominal discomfort or mild pain as the gallbladder contracts during the diagnostic procedure.

Sincalide for Injection 5 mcg is manufactured by Avir Pharma Inc. in Canada.

Yes, it should be handled and administered by healthcare professionals, with monitoring for any adverse reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.